Vitiello B, Stover E S
National Institute of Mental Health, Office on AIDS, Rockville, MD 20857, USA.
Psychopharmacol Bull. 1996;32(3):293-7.
Psychotropic medications play an important role in the treatment of human immunodeficiency virus (HIV)-positive subjects suffering from neuropsychiatric disorders or other acquired immunodeficiency syndrome (AIDS)-related symptomatology. The quality of life of these patients can be significantly improved by the appropriate use of these agents. Various aspects of psychopharmacology that are relevant to HIV-positive patients include assessment of efficacy, tolerability, drug-drug interactions, and effects on cognition. These topics need further investigation and require focused research efforts. This report highlights current research needs and presents specific recommendations that emerged at a recent meeting on psychopharmacology for HIV-positive patients organized by the National Institute of Mental Health (NIMH).
精神药物在治疗患有神经精神障碍或其他与获得性免疫缺陷综合征（AIDS）相关症状的人类免疫缺陷病毒（HIV）阳性患者中发挥着重要作用。合理使用这些药物可显著改善这些患者的生活质量。与HIV阳性患者相关的精神药理学的各个方面包括疗效评估、耐受性、药物相互作用以及对认知的影响。这些主题需要进一步研究，并需要集中的研究努力。本报告强调了当前的研究需求，并提出了在国家心理健康研究所（NIMH）最近组织的一次关于HIV阳性患者精神药理学的会议上提出的具体建议。
